[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anika Therapeutics 32 WIGGINS AVENUE BEDFORD MA 01730 USA

www.anika.com Employees: 235 P: 781-457-9000 F: 781-305-9720

Sector:

Medical

Description:

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.

Key Statistics

Overview:

Market Capitalization, $K 287,333
Enterprise Value, $K 229,853
Shares Outstanding, K 13,383
Float, K 11,766
% Float 87.92%
Short Interest, K 308
Short Float 2.30%
Days to Cover 4.34
Short Volume Ratio 0.35
% of Insider Shareholders 12.08%
% of Institutional Shareholders 91.53%

Financials:

Annual Sales, $ 112,820 K
Annual Net Income, $ -10,880 K
Last Quarter Sales, $ 32,610 K
Last Quarter Net Income, $ 3,310 K
EBIT, $ -5,120 K
EBITDA, $ 610 K

Growth:

1-Year Return 148.22%
3-Year Return 15.43%
5-Year Return -49.07%
5-Year Revenue Growth -13.52%
5-Year Earnings Growth -192.96%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.42 on 07/29/26
Next Earnings Date 11/04/26
Earnings Per Share ttm 0.02
EPS Growth vs. Prev Qtr 225.00%
EPS Growth vs. Prev Year 190.91%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANIK Ratios

Ratio
Price/Earnings ttm 1,075.00
Price/Earnings forward 153.57
Price/Earnings to Growth 15.36
Return-on-Equity % 0.20%
Return-on-Assets % 0.15%
Profit Margin % -9.64%
Debt/Equity 0.00
Price/Sales 2.55
Price/Cash Flow N/A
Price/Book 2.10
Book Value/Share 10.26
Interest Coverage -0.81
60-Month Beta 0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.